dione image Pioglitazone.svg width 200 imagename 1 1 mixture racemate drug name Pioglitazone Clinical data tradename Actos Drugs.com drugs.com monograph pioglitazone hydrochloride MedlinePlus a699016 ... StdInChIKey HYAFETHFCAUJAY UHFFFAOYSA N Pioglitazone is a prescription drug of the class thiazolidinedione ... diabetes . Pioglitazone is marketed as trademarks Actos in the USA, Canada, the UK and Germany, Glustin ... events. However, pioglitazone has subsequently been found to be associated with bladder tumors and has been withdrawn in some countries. Pharmacology Pioglitazone selectively stimulates the nuclear ... name pmid10983737 cite journal title Pioglitazone journal Drugs volume 60 issue 2 pages 333 43 discussion ... Pioglitazone mechanism of action journal Int J Clin Pract Suppl volume issue 121 pages 13 8 year 2001 ... . As a result, pioglitazone reduces insulin resistance in the liver and peripheral tissues ... significant, pioglitazone decreases the level of triglycerides and increases that of high density ... for this. More recently, When date March 2011 pioglitazone and other active TZDs have been shown ... comparable to that of pioglitazone for PPAR . ref name pmid14570702 cite journal title Identification ... membrane protein stabilized by pioglitazone journal Proc. Natl. Acad. Sci. U.S.A. volume 104 issue ... ref Indications and usage Pioglitazone is used for the treatment of diabetes mellitus type 2 previously ... , metformin , or insulin . Pioglitazone has also been used to treat non alcoholic ... Tio first9 F title A placebo controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis ... 2297 307 year 2006 month November pmid 17135584 doi 10.1056 NEJMoa060326 ref Pioglitazone has also ... cite web last DeFronzo first Ralph A. title Pioglitazone for Diabetes Prevention in Impaired Glucose ... accessdate March 29, 2011 ref Contraindication Unreferenced section date March 2011 Pioglitazone cannot be used in patients with a known hypersensitivity to pioglitazone, other thiazolidinediones or any ... more details
Unreferenced date January 2007 Orphan date May 2008 Politor is the brand name of the Pioglitazone and Metformin combination preparation Pioglitazone 15 mg and Metformin 500 mg tablet and Pioglitazone 15 mg and Metformin 850 mg tablet from ACI Pharmaceuticals Bangladesh . It is also .... under the brand name of Actoplus Met. Politor contains two oral antihyperglycemic agents pioglitazone ... control in patients with Diabetes mellitus type 2 . Mechanisms Pioglitazone is a member of the thiazolidinedione ... combination of pioglitazone and metformin, For patients whose diabetes is not adequately controlled with metformin alone, or For patients who have initially responded to pioglitazone alone ... daily dose of pioglitazone 45 mg and metformin 2550 mg. Starting dose for patients who initially responded to pioglitazone monotherapy and require additional glycemic control Based on the usual ... controlled on metformin monotherapy Based on the usual starting dose of pioglitazone 15 30 ... dose for patients switching from combination therapy of pioglitazone plus metformin as separate ... strengths based on the dose of pioglitazone and metformin already being taken. Use in pregnancy and lactation Politor pioglitazone and metformin should not be used during pregnancy unless the potential ... studies in pregnant women with combination of pioglitazone and metformin or its individual components. It is not known whether pioglitazone and or metformin are secreted in human milk. Because many drugs ... Politor pioglitazone and metformin should not be used in patients with type I diabetes or for the treatment ... ALT levels should be evaluated prior to the initiation of therapy with combination of pioglitazone ... similar between groups treated with pioglitazone in combination with metformin and those treated with pioglitazone monotherapy. Contraindications Politor pioglitazone and metformin is contraindicated ... coma. Drug interaction Politor pioglitazone and metformin may interact with furosemide, nifedipine ... more details
and withdrawn from the market in Europe due to an increased risk of cardiovascular events. Pioglitazone ... the drug, also known as pioglitazone, could raise the risk of bladder cancer. ref http www.huliq.com ... K, et al. title A placebo controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis ... 16494655 doi 10.1111 j.1368 5031.2005.00765.x url ref autism , ref Boris et al. Effect of pioglitazone ... complication. To date, 2008, the newer thiazolidinediones, rosiglitazone and pioglitazone have ... 10 21 ref pioglitazone treatment, in contrast, has shown significant protection from both micro and macro ... Charbonnel B, Dormandy J, Erdmann E, Massi Benedetti M, Skene A title The prospective pioglitazone clinical trial in macrovascular events PROactive can pioglitazone reduce cardiovascular events in diabetes ... cgi content abstract 27 7 1647 ref ref name Pioglitazone and cardiovascular risk cite journal author Mannucci E, Monami M, Lamanna C, Gensini GF, Marchionni N title Pioglitazone .... title Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients ... with a substantial decrease in rosiglitazone use. Despite a class level FDA advisory, pioglitazone ... indicated a possible link between pioglitazone Actos and bladder cancer . The findings prompted ... news last Peck first Peggy title FDA Says It Will Review Pioglitazone Safety url http www.medpagetoday.com ... more details
antiglycemic drug s may alter the course of the disease. A randomized controlled trial found that pioglitazone ... controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis journal N. Engl. J ... to insulin sensitizer in one large study. In the Pioglitazone versus Vitamin E versus Placebo for the Treatment ... by biopsy but it did not improve fibrosis. Pioglitazone, an insulin sensitizer, improved some features ... which persisted after pioglitazone was discontinued. ref name Sanyal cite journal author Sanyal AJ, Chalasani N, Kowdley KV, et al. title Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis ... more details
blind, randomized, pioglitazone comparative study journal Diabetes Care volume 29 issue 5 pages 1016 ... with metformin monotherapy A double blind, randomized, pioglitazone comparative study journal Diabetes ... url ref comparing muraglitazar and pioglitazone found that the effects of the former were favourable ... and heart failure and more weight gain compared to the pioglitazone group. A meta analysis of the phase ... CHF when compared to placebo or pioglitazone. ref name pmid16239637 cite journal author Nissen SE, Wolski ... more details
chembox verifiedrevid 349493724 ImageFile Thiazolidine numbering.png ImageSize 100px IUPACName Thiazolidine OtherNames Section1 Chembox Identifiers CASNo 504 78 9 PubChem 10444 SMILES C1CSCN1 Section2 Chembox Properties Formula C sub 3 sub H sub 7 sub NS MolarMass 89.16 g mol Appearance Density 1.131 g cm sup 3 sup MeltingPt BoilingPt 72 75 C at 25 torr Solubility Section3 Chembox Hazards MainHazards FlashPt Autoignition Thiazolidines are a class of heterocyclic organic compound s with a 5 membered saturation chemistry saturated ring with a thioether group and an amine group in the 1 and 3 positions, respectively. It is a sulfur analogue of oxazolidine . The drug pioglitazone contains a thiazolidine ring. It is a drug usually indicated in cases of type II diabetes for decreasing blood sugar. It also decreases triglycerides and C reactive protein levels. It lowers blood pressure and increases levels of HDL. Another drug which contains a thiazolidine ring is the antibiotic drug penicillin. Thiazolidines may be synthesized by a condensation reaction between a thiol and an aldehyde or ketone . The reaction is reversible. Therefore, many thiazolidines are labile towards hydrolysis in aqueous solution. Hydrolysis of the thiazolidine generates the thiol and aldehyde or ketone from which it was synthesized. References heterocyclic stub Category Thiazolidines de Thiazolidin fa nl Thiazolidine pl Tiazolidyna ... more details
protein Name CDGSH iron sulfur domain 1 caption Crystallographic structure PDB 2QH7 of the CDGSH type domain 1 dimer green and cyan cartoon complexed with iron brown and sulfur yellow Fe S clusters. image 2QH7.png width HGNCid 30880 Symbol CISD1 AltSymbols C10orf70, ZCD1 EntrezGene 55847 OMIM RefSeq NM 018464 UniProt Q9NZ45 PDB 2QH7 ECnumber Chromosome 10 Arm q Band 21.3 LocusSupplementaryData protein Name CDGSH iron sulfur domain 1B caption image width HGNCid 29611 Symbol CISD1B AltSymbols ZCD1B EntrezGene 130500 OMIM RefSeq XM 065750 UniProt PDB ECnumber Chromosome 2 Arm p Band 24.1 LocusSupplementaryData protein Name CDGSH iron sulfur domain 2 caption image width HGNCid 24212 Symbol CISD2 AltSymbols ZCD2 EntrezGene 493856 OMIM RefSeq NM 001008388 UniProt Q7Z3D5 PDB ECnumber Chromosome 4 Arm q Band 24 LocusSupplementaryData protein Name CDGSH iron sulfur domain 3 caption image width HGNCid 27578 Symbol CISD3 AltSymbols EntrezGene 284106 OMIM RefSeq UniProt PDB ECnumber Chromosome 17 Arm q Band 12 LocusSupplementaryData The CDGSH iron sulfur domain are a group of iron sulfur Fe S clusters and a unique 39 amino acid CDGSH domain C X C X2 S T X3 P X C D G S A T H . The CDGSH iron sulfur domain 1 protein also referred to as mitoNEET is an integral membrane protein located in the outer mitochondrial membrane and whose function may be to transport iron into the mitochondria. ref name pmid17766440 cite journal author Paddock ML, Wiley SE, Axelrod HL, Cohen AE, Roy M, Abresch EC, Capraro D, Murphy AN, Nechushtai R, Dixon JE, Jennings PA title MitoNEET is a uniquely folded 2Fe 2S outer mitochondrial membrane protein stabilized by pioglitazone journal Proc. Natl. Acad. Sci. U.S.A. volume 104 issue 36 pages 14342 7 year 2007 pmid 17766440 doi 10.1073 pnas.0707189104 pmc 1963346 ref Iron in turn is essential for the function of several mitochondrial enzymes . The antidiabetic drug pioglitazone , in addition to binding to the nuclear receptor PPAR , also has been shown to bind ... more details
aimed to demonstrate the efficacy of alogliptin as an add on agent in combination with metformin and pioglitazone versus simply increasing the dosage of pioglitazone in combination with metformin in other ... of this study suggested that the addition of alogliptin to metformin and pioglitazone provided superior impact on diabetes biomarkers e.g. HbA1c than increasing the dose of pioglitazone in a two agent ... of NDAs one for alogliptin and a second for a combination of alogliptin and pioglitazone in July 2011 ... glycaemic control on metformin and pioglitazone a 52 week, randomized, double blind, active ... more details
of a new insulin sensitizing agent, pioglitazone language Japanese journal Yakugaku Zasshi ... were later developed, some of which such as pioglitazone and troglitazone made it to the market ... more details
Drugbox Verifiedfields changed verifiedrevid 470477813 Clinical data tradename pregnancy AU A B1 B2 B3 C D X pregnancy US A B C D X legal AU S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled legal CA Schedule I, II, III, IV, V, VI, VII, VIII legal UK GSL, P, POM, CD, or Class A, B, C legal US OTC Rx only Schedule I, II, III, IV, V routes of administration subcutaneous Pharmacokinetic data bioavailability N A Identifiers CAS number Ref cascite changed ?? CAS number 275371 94 3 ATC prefix none DrugBank Ref drugbankcite correct drugbank UNII Ref fdacite correct FDA UNII 2PHK27IP3B ChemSpiderID Ref chemspidercite correct chemspider ChemSpiderID NA Chemical data C 152 H 232 N 40 O 45 molecular weight 3339.75 g mol Taspoglutide is a pharmaceutical drug . It is a glucagon like peptide 1 analog , under investigation for treatment of type 2 diabetes being codeveloped by Ipsen and Hoffmann La Roche Roche . ref cite news url http findarticles.com p articles mi m0EIN is 2008 June 10 ai n25492242 title Ipsen Roche Moves Investigational Diabetes Drug, Taspoglutide, into Phase III Clinical Trials date June 2008 work Business Wire ref ref cite web url http www.bio medicine.org medicine technology 1 Roche Moves Investigational Diabetes Drug Taspoglutide Into Phase III Clinical Trials 2379 1 title Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials date June 2008 ref Two phase II trials reported it was effective and well tolerated. ref name Baggio2008 cite web url http www.medscape.com viewarticle 578304 title Glucagon like Peptide 1 Analogs Other Than Exenatide year 2008 author Baggio et al. ref Of the eight planned phase III clinical trials of weekly taspoglutide four against exenatide , sitagliptin , insulin glargine , and pioglitazone , at least five were active in 2009. ref cite web url http www.medicalnewstoday.com articles 169171.php title Ipsen s Partner Roche Announces That Taspoglutide Meets Its Primary Endpoint In The First Phase III Clinica ... more details
of pioglitazone in subjects nonalcoholic steatohepatitis journal N. Engl. J. Med. volume 355 issue 22 ... study. In the Pioglitazone versus Vitamin E versus Placebo for the Treatment of Nondiabetic Patients .... Pioglitazone, an insulin sensitizer, improved some features of NASH but not the primary outcome, and resulted in a significant weight gain mean 4.7 kilograms which persisted after pioglitazone ... Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis journal N. Engl. J. Med. volume ... more details
than pioglitazone Actos , and have recommended rosiglitazone be taken off the market, but an FDA Food ... patients, comparing roziglitazone to pioglitazone, the other thiazolidinedione marketed in the United ... or Pioglitazone. JAMA. 2010 304 4 doi 10.1001 jama.2010.920 http www.bmj.com cgi content ... a similar agent, pioglitazone. The meta analysis had 16 observational studies involving 810 000 patients taking rosiglitazone or pioglitazone . ref cite web last Hughes first Sue title More damning data ... 17145742 doi 10.1056 NEJMoa066224 ref The same increase has been found with pioglitazone Actos , another TZD. Eye damage Both rosiglitazone and pioglitazone have been suspected of causing macular ... and to those, who in consultation with their healthcare provider, have decided not to take Actos pioglitazone or other pioglitazone containing medicines for medical reasons. ref cite web title GSK revises ... more details
such as pioglitazone or rosiglitazone . In its Byetta form, during 2011 it was approved by the FDA ... compared to pioglitazone Actos , the DPP 4 inhibitor sitagliptin Januvia and the basal insulin glargine ... sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes DURATION 2 a randomised ... more details
suspension of Avandia, Avandamet and Avaglim , EMA , 23 September 2009 ref pioglitazone Actos ... one large prospective study, PROactive 05, has shown that pioglitazone may decrease the overall ... B first4 M first5 IK first6 AM first7 Investigators title The effect of pioglitazone on recurrent ... more details
Encyclopedia
top
